(BMEZ) BlackRock Health Sciences - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US09260E1055
BMEZ: Pharmaceuticals, Biotechnology, Medical Devices, Healthcare Services
Ticker Symbol: BMEZ | Exchange: NYSE | Type: Common Stock | Country Origin: United States | GICS Sub Industry: Health Care Services
Average Volume 20d: 349,964 | Last Price: 14.91 | SMA 20: 15.16 | SMA 50: 15.53 | SMA 200: 14.77 | ATR: 0.25
Market Cap: $1,529.96M USD | P/E: 71.95 | P/B: 0.92 | P/S: 62.06 | RoE: None
3-Month Forecast: Based on the moving averages, BMEZ is trading below its SMA 20 and SMA 50, signaling a bearish trend. However, the SMA 200 is slightly below the current price, suggesting potential support. The low ATR of 0.25 indicates reduced volatility. With a forward P/E of 0.00, the stock may face uncertainty. Expect sideways movement with potential upside if the price breaks above the SMA 50.
Additional Sources for BMEZ Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BMEZ Stock Overview
| Market Cap in USD | 1,438m |
| GiC Sub-Industry | Health Care Services |
| IPO / Inception | 2020-01-29 |
BMEZ Stock Ratings
| Growth Rating | 7.57 |
| Fundamental | - |
| Dividend Rating | 90.4 |
| Rel. Strength | 8.04 |
| Analysts | - |
| Fair Price Momentum | 14.66 USD |
| Fair Price DCF | 23.26 USD |
BMEZ Dividends
| Dividend Yield 12m | 14.45% |
| Yield on Cost 5y | 16.47% |
| Annual Growth 5y | 13.43% |
| Payout Consistency | 97.7% |
BMEZ Growth Ratios
| Growth Correlation 3m | -90.5% |
| Growth Correlation 12m | 69.8% |
| Growth Correlation 5y | -32.6% |
| CAGR 5y | 2.03% |
| CAGR/Max DD 5y | 0.04 |
| Sharpe Ratio 12m | -0.64 |
| Alpha | 1.89 |
| Beta | 0.541 |
| Volatility | 32.61% |
| Current Volume | 300.9k |
| Average Volume 20d | 452.8k |
What is the price of BMEZ stocks?
As of April 19, 2025, the stock is trading at USD 13.66 with a total of 300,900 shares traded.
Over the past week, the price has changed by -0.79%, over one month by -8.29%, over three months by -12.28% and over the past year by +7.46%.
As of April 19, 2025, the stock is trading at USD 13.66 with a total of 300,900 shares traded.
Over the past week, the price has changed by -0.79%, over one month by -8.29%, over three months by -12.28% and over the past year by +7.46%.
Is BlackRock Health Sciences a good stock to buy?
Neither. Based on ValueRay Analyses, BlackRock Health Sciences is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 7.57 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BMEZ as of April 2025 is 14.66. This means that BMEZ is currently overvalued and has a potential downside of 7.32%.
Neither. Based on ValueRay Analyses, BlackRock Health Sciences is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 7.57 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BMEZ as of April 2025 is 14.66. This means that BMEZ is currently overvalued and has a potential downside of 7.32%.
Is BMEZ a buy, sell or hold?
BlackRock Health Sciences has no consensus analysts rating.
BlackRock Health Sciences has no consensus analysts rating.
What are the forecast for BMEZ stock price target?
According to ValueRays Forecast Model, BMEZ BlackRock Health Sciences will be worth about 16 in April 2026. The stock is currently trading at 13.66. This means that the stock has a potential upside of +17.28%.
According to ValueRays Forecast Model, BMEZ BlackRock Health Sciences will be worth about 16 in April 2026. The stock is currently trading at 13.66. This means that the stock has a potential upside of +17.28%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 16 | 17.3% |